Kannrybio | Implant-grade Bioactive Ceramics & Calcium Phosphate Powders
Applications / Material Systems · March 2025 · Author: Neo · Technical review: Alex

45S5 Bioactive Glass Microspheres - A Practical Functional Phase for Composite Bone Repair Systems

Explore how 45S5 bioactive glass microspheres fit composite bone repair systems - better handling, configurable particle sizes, and practical integration into CPC and scaffolds.

Reading time: ~2 min Keyword focus: implant‑grade · ISO 13485 · OEM ← Back to News

45S5 bioactive glass is well known for its bioactivity in bone regeneration and related biomedical applications. In microsphere form, it becomes even more manufacturing-friendly - offering better flow, packing, and integration into composite systems such as calcium phosphate, polymers, and injectable platforms.

Why microspheres matter

  • Better flow and handling: Microspheres often improve dosing, mixing, and processing consistency versus irregular powders.
  • A functional additive in composites: 45S5 microspheres are frequently used as a bioactivity booster in CaP-based or polymer-based systems.
  • Process-oriented customization: Particle size range and surface characteristics can be tailored to your processing window and performance targets.

Typical application directions

  • CaP composites (HA / β-TCP / α-TCP) for enhanced bioactivity.
  • Injectable bone repair materials and cement modification.
  • Porous scaffolds and composite scaffolds.
  • Dental bone grafting and regenerative material systems.

If you are developing a composite formulation, define your target size range, mixing ratio, and process route (injectable, molding, printing, sintering, etc.). We can align microsphere parameters to your manufacturing constraints and validation plan.

References

  1. ISO 13485:2016 — Medical devices — Quality management systems — Requirements for regulatory purposes
  2. ISO 14971:2019 — Medical devices — Application of risk management to medical devices
  3. ISO 10993-18:2020 — Biological evaluation of medical devices — Part 18: Chemical characterization of medical device materials within a risk management process

These standards are cited for context and do not, by themselves, state product certification or compliance.

OEM / R&D SUPPORT

If you’re evaluating materials for an implant program or OEM supply chain, we can share sample COA formats, typical parameter ranges, and a practical sampling plan for your internal review.


Contact: info@kannrybio.com · Tel: +8619822625826 · WhatsApp: +8615152105933